Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10216469

Download in:

View as

General Info

PMID
10216469